secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-09-18T23:59:59+00:00
Accession:  0001213900-23-077392
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition Corp. extends deadline to Oct 19, 2023; Estrella deposits $37,432.70 into trust
--------------------------------------------------------------------------------

- Monthly extension fee of $37,432.70 ($0.05 per Remaining Share) deposited into trust account to extend deadline from Sept 19 to Oct 19, 2023.
- Payment made by Estrella Biopharma pursuant to Merger Agreement dated Sept 30, 2022; evidenced by unsecured, non-interest-bearing promissory note.
- Extension Note convertible into common stock of TradeUP at $10.00 per share; repayable if business combination terminates.
- Company may extend monthly from July 19, 2023 to July 14, 2024 by depositing Monthly Extension Fee each month.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390023077392/0001213900-23-077392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390023077392/ea185365-8k425_tradeup.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-077392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer